The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALKERMES PLC | SHS | G01767105 | 128,105 | 3,166,348 | SH | DFND | 1 | 0 | 3,166,348 | 0 | |
ALKERMES PLC | SHS | G01767105 | 59,157 | 1,462,163 | SH | DFND | 2 | 0 | 1,462,163 | 0 | |
ALKERMES PLC | SHS | G01767105 | 65,350 | 1,615,238 | SH | DFND | 3 | 0 | 1,615,238 | 0 | |
ALKERMES PLC | SHS | G01767105 | 58,016 | 1,341,934 | SH | DFND | 0 | 1,080,999 | 260,935 | ||
BIOGEN INC | Common | 09062X103 | 36,302 | 112,313 | SH | DFND | 2 | 0 | 112,313 | 0 | |
BIOGEN INC | Common | 09062X103 | 26,449 | 154,151 | SH | DFND | 3 | 0 | 154,151 | 0 | |
BIOGEN INC | Common | 09062X103 | 24,516 | 104,100 | SH | DFND | 0 | 104,100 | 0 | ||
BIOVERATIV INC | Common | 09075E100 | 19,481 | 488,732 | SH | DFND | 2 | 0 | 488,732 | 0 | |
BIOVERATIV INC | Common | 09075E100 | 30,492 | 764,986 | SH | DFND | 3 | 0 | 764,986 | 0 | |
BIOVERATIV INC | Common | 09075E100 | 29,519 | 694,607 | SH | DFND | 0 | 564,257 | 130,350 | ||
GILEAD SCIENCES INC | Common | 375558103 | 33,645 | 509,197 | SH | DFND | 2 | 0 | 509,197 | 0 | |
GILEAD SCIENCES INC | Common | 375558103 | 26,966 | 635,310 | SH | DFND | 3 | 0 | 635,310 | 0 | |
GILEAD SCIENCES INC | Common | 375558103 | 23,030 | 434,846 | SH | DFND | 0 | 434,846 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 212,976 | 7,684,790 | SH | DFND | 1 | 0 | 7,684,790 | 0 | |
PROTHENA CORP PLC | SHS | G72800108 | 70,682 | 2,550,408 | SH | DFND | 4 | 0 | 2,550,408 | 0 | |
PROTHENA CORP PLC | SHS | G72800108 | 41,565 | 1,293,416 | SH | DFND | 0 | 708,342 | 585,074 | ||
THERAVANCE BIOPHARMA INC | Common | G8807B106 | 167,308 | 8,114,946 | SH | DFND | 1 | 0 | 8,114,946 | 0 | |
THERAVANCE BIOPHARMA INC | Common | G8807B106 | 29,439 | 1,427,893 | SH | DFND | 4 | 0 | 1,427,893 | 0 | |
THERAVANCE BIOPHARMA INC | Common | G8807B106 | 30,523 | 1,204,269 | SH | DFND | 0 | 421,270 | 782,999 |